The potential of IL-6 to enhance tumor growth and progression by autocrine and paracrine effects and to produce particular immunological and metabolism changes that influence prognosis has been convincingly shown in ovarian cancer (Berek et al., 1991; Lo et al., 2011). This evidence concerns the gene IL6 and neoplasm.